An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment
Clinical trial NCT01074333 · TERMINATED
Trial details
- NCT number
- NCT01074333
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-12-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.